Germany· DE-A57-f4ef14ba5a77b807
Piritramid Hameln
A piritramide product containing piritramide, registered in Germany by Hameln Pharma Gmbh. The same ATC class is registered in 4 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Piritramide is registered in 4 of 19 countries.
Countries holding a registration under ATC N02AC03 (piritramide), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 2 of them publish a price we can compare per daily dose
Piritramide · ATC N02AC03
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Germany
- Netherlands
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Piritramide
- Manufacturer
- Hameln Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- N02AC03
- ATC class
- Piritramide
- Defined daily dose
- 45 mg, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Piritramide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDIPIDOLORPiramal Critical Care B.V., Voorschoten
- BelgiumDipidolor 10 mg/mlPiramal Critical Care
- NetherlandsDipidolor oplossing voor injectie 10 mg/ml, oplossing voor injectiePiramal Critical Care B.V.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Dipidolor, Piritramid Hameln
- Belgium · Dipidolor
- Czechia · Dipidolor, Piritramid Hameln
- Luxembourg · Dipidolor
- Netherlands · Dipidolor
- Slovenia · Hameln, Piritramid Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9904f24-df34-4b6c-9920-c68148c97083 GET /v1/drugs/b9904f24-df34-4b6c-9920-c68148c97083?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use ,Subcutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Piritramide",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about piritramide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.